These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 21896146)

  • 1. Central sympatholytic drugs.
    Vongpatanasin W; Kario K; Atlas SA; Victor RG
    J Clin Hypertens (Greenwich); 2011 Sep; 13(9):658-61. PubMed ID: 21896146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.
    Esler M; Kaye D
    J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guanabenz combination therapy inhibits sympathetic nerve activity and regresses left ventricular hypertrophy.
    Miyajima E; Shigemasa T; Endo T; Hishiki S; Kawano Y
    Cardiovasc Drugs Ther; 2000 Feb; 14(1):61-6. PubMed ID: 10755202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Central nervous system as a target for the new antihypertensive agents].
    Nurminen ML
    Duodecim; 1999; 115(20):2267-73. PubMed ID: 11973931
    [No Abstract]   [Full Text] [Related]  

  • 5. Direct Vasodilators and Sympatholytic Agents.
    McComb MN; Chao JY; Ng TM
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):3-19. PubMed ID: 26033778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Centrally-acting antihypertensive drugs].
    Takishita S; Yamazato M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():591-5. PubMed ID: 15171442
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological properties of the central antihypertensive agent, moxonidine.
    Edwards LP; Brown-Bryan TA; McLean L; Ernsberger P
    Cardiovasc Ther; 2012 Aug; 30(4):199-208. PubMed ID: 21884003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renaissance of centrally acting antihypertensive drugs.
    van Zwieten PA
    J Hypertens Suppl; 1999 Aug; 17(3):S15-21. PubMed ID: 10489094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do most antihypertensive agents have a sympatholytic action?
    de Champlain J
    Curr Hypertens Rep; 2001 Aug; 3(4):305-13. PubMed ID: 11470013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centrally acting antihypertensives: not obsolete after all.
    Schachter M
    Int J Clin Pract; 1998; 52(3):192-5. PubMed ID: 9684437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of drugs modifying sympathetic nervous system activity in the treatment of hypertension.
    Peart S
    J Hypertens Suppl; 1985 Dec; 3(4):S51-5. PubMed ID: 3007706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Centrally acting sympathetic inhibitors for therapy of patients with hypertension].
    Kawasaki H
    Nihon Rinsho; 1997 Aug; 55(8):2081-5. PubMed ID: 9284427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathomodulatory Effects of Antihypertensive Drug Treatment.
    Grassi G
    Am J Hypertens; 2016 Jun; 29(6):665-75. PubMed ID: 26888777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rilmenidine sympatholytic activity preserves mental stress, orthostatic sympathetic responses and adrenaline secretion.
    Esler M; Lux A; Jennings G; Hastings J; Socratous F; Lambert G
    J Hypertens; 2004 Aug; 22(8):1529-34. PubMed ID: 15257176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of clonidine in patients with essential hypertension with neurovascular contact of the rostral ventrolateral medulla.
    Sakuma T; Morimoto S; Aota Y; Takahashi N; Toyoda N; Kosaki A; Maehara M; Tanigawa N; Ikeda K; Sawada S; Iwasaka T
    Hypertens Res; 2010 Jun; 33(6):633-7. PubMed ID: 20379192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of three antihypertensive drug groups on lipid metabolism. Effects of alpha receptor blockers, central sympatholytic drugs and vasodilators].
    Jacob BG; Richter WO; Schwandt P
    Fortschr Med; 1993 Mar; 111(8):126-9. PubMed ID: 8099558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central and peripheral blockade of the sympathetic nervous system.
    Weber MA; Drayer JI
    Am J Med; 1984 Oct; 77(4A):110-8. PubMed ID: 6148889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of doxazosin and hydralazine on insulin sensitivity and sympathetic function in spontaneously hypertensive rat (SHR)].
    Takahashi A; Kushiro T; Kanmatsuse K
    Nihon Jinzo Gakkai Shi; 1998 May; 40(4):240-4. PubMed ID: 9654906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sympathoexcitatory responses to the acute blood pressure fall induced by central or peripheral antihypertensive drugs.
    Grassi G; Seravalle G; Stella ML; Turri C; Zanchetti A; Mancia G
    Am J Hypertens; 2000 Jan; 13(1 Pt 1):29-34. PubMed ID: 10678268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.